Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn’s disease: a case-control study

dc.contributor.authorRodríguez Lago, Iago
dc.contributor.authorAduna, Marta
dc.contributor.authorRamírez de la Piscina, Patricia
dc.contributor.authorMerino, Olga
dc.contributor.authorCarrascosa, Juan
dc.contributor.authorHiguera, Rebeca
dc.contributor.authorMaíz, Ainara
dc.contributor.authorZapata, Eva
dc.contributor.authorCabriada, José Luis
dc.contributor.authorBarreiro de Acosta, Manuel
dc.date.accessioned2024-11-22T10:53:46Z
dc.date.available2024-11-22T10:53:46Z
dc.date.issued2024-06-14
dc.date.updated2024-11-22T10:53:46Z
dc.description.abstractPurpose: Crohn’s disease (CD) is a progressive disorder leading to cumulative bowel damage. The Lémann index is a validated tool that can help in monitoring the progression of the disease and evaluating the effectiveness of different therapies. Our aim was to describe the main radiological findings in incidentally diagnosed CD and to evaluate bowel damage in this subgroup compared to patients diagnosed at later stages. Methods: Patients with an incidental diagnosis of CD during the colorectal cancer screening program were compared to controls with a CD cohort diagnosed after symptomatic onset and matched 1:1 by disease extent. All cross-sectional examinations were centrally read, performing a descriptive analysis of the main findings and calculation of Lémann index. Results: Thirty-eight patients were included: 19 with preclinical CD (median age 55 years (IQR, 54–62), 53% male, 74% non-smokers; 74% B1 and 26% B2) and 19 matched-controls with symptomatic CD. In those with preclinical CD, the most frequent transmural findings on MRE were contrast enhancement (79%), wall thickening (79%), followed by lymphadenopathy (68%), edema (42%), and increased vascularity (42%). Among those with strictures, controls showed a higher rate of preestenotic dilation (100% vs. 0%, p = 0.01). Bowel damage assessment revealed no statistically significant differences in the Lémann index between preclinical CD and controls (p = 0.95). A statistically significant higher score in the colonic/rectum score was observed (p = 0.014). Conclusion: Patients with preclinical CD demonstrate similar radiological findings and degree of bowel damage as new-onset symptomatic CD.en
dc.identifier.citationRodríguez-Lago, I., Aduna, M., Ramírez de la Piscina, P., Merino, O., Carrascosa, J., Higuera, R., Maíz, A., Zapata, E., Cabriada, J. L., & Barreiro-de Acosta, M. (2024). Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn’s disease: a case-control study. International Journal of Colorectal Disease, 39(1). https://doi.org/10.1007/S00384-024-04660-5
dc.identifier.doi10.1007/S00384-024-04660-5
dc.identifier.eissn1432-1262
dc.identifier.issn0179-1958
dc.identifier.urihttp://hdl.handle.net/20.500.14454/2096
dc.language.isoeng
dc.publisherSpringer Nature
dc.rights© The Author(s) 2024
dc.subject.otherBowel damage
dc.subject.otherCrohn’s disease
dc.subject.otherDiagnosis
dc.subject.otherEarly
dc.subject.otherPreclinical
dc.titleTransmural cross-sectional findings and bowel damage assessment in preclinical Crohn’s disease: a case-control studyen
dc.typejournal article
dcterms.accessRightsopen access
oaire.citation.issue1
oaire.citation.titleInternational Journal of Colorectal Disease
oaire.citation.volume39
oaire.licenseConditionhttps://creativecommons.org/licenses/by/4.0/
oaire.versionVoR
Ficheros en el ítem
Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
rodriguez_transmural_2024.pdf
Tamaño:
574.98 KB
Formato:
Adobe Portable Document Format
Colecciones